Robeauté | Latest News & Updates - Jan 15, 2025 Release
Robeauté raised $28M in funding to support its US market entry and pursue FDA approval...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
Robeauté
🌎 robeaute.comRobeauté is a medical equipment manufacturing company based in Paris, specializing in the development of therapeutic microrobots designed for neurosurgery. Their innovative microrobots, smaller than a grain of rice, aim to provide surgeons with enhanced access to delicate areas of the brain and other hard-to-reach regions of the body. The company is focused on advancing microrobotic surgery, enabling precise interventions and localized therapies to improve treatment outcomes for various diseases.
Robeauté - Latest News and Updates
- Robeauté raised $28M in funding to support its US market entry and pursue FDA approval.
- Robeauté secured €27 million in funding led by Plural, Cherry Ventures, and Kindred Ventures to advance its microrobotic technology for brain pathologies and plans to start clinical trials by 2026 and expand to the US for FDA approval.
- Joana Cartocci, Co-founder and COO at Robeauté, announced her participation in the JPM event in San Francisco to engage with the neuro community and industry partners.
- Robeauté will present a startup pitch at the PSCC Innovation Forum 2025.
- Sophia-Hanna KOURA has joined Robeauté as a Biomechanical Engineering Intern in France.
- Robeauté is hiring a QA/RA Specialist in Paris to manage regulatory processes with the FDA and EMA and oversee quality management at their manufacturing site.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.